Regional Analysis
- North America: The U.S. leads with high OSA prevalence, while Canada focuses on TMD care.
- Europe: Germany, France, and the UK drive demand due to advanced sleep clinics.
- Asia Pacific: China sees growth from obesity, while Japan emphasizes elderly OSA care.
- Rest of the World: Brazil expands sleep services, and the Middle East invests in dental health.
Application Analysis
- Homecare: Expected growth of 5.3%-7.6%, driven by OSA patients. Trends focus on smart devices.
- Hospitals & Clinics: Projected growth of 5.2%-7.5%, linked to TMD treatment. Developments emphasize precision.
- Others: Anticipated growth of 5.1%-7.4%, covering dental aesthetics. Advances prioritize comfort.
Type Analysis
- Mandibular Advancement Devices (MADs): Expected growth of 5.3%-7.6%, valued for OSA efficacy. Trends highlight digital customization.
- Tongue Retaining Devices (TRDs): Projected growth of 5.1%-7.4%, key for non-compliant patients. Advances focus on comfort.
- Hybrid Devices: Anticipated growth of 5.4%-7.7%, driven by versatility. Innovations emphasize multifunctionality.
Key Market Players
Leading firms include ResMed, offering sleep solutions; SomnoMed, enhancing MADs; ProSomnus, advancing precision devices; Vivos, targeting OSA; Glidewell, launching Silent Nite; Airway Management, offering myTAP; Mitsui Chemicals, boosting materials; Signifier Medical Technologies, innovating in sleep; Achaemenid, scaling solutions; and Apnea Sciences, focusing on TRDs.Porter's Five Forces Analysis
- Threat of New Entrants: Moderate, due to regulatory and tech barriers, though smart device innovators can enter.
- Threat of Substitutes: Moderate, as CPAP and surgery compete, but oral appliances offer unique comfort.
- Bargaining Power of Buyers: Moderate, with patients seeking effective, comfortable devices, though clinical needs limit options.
- Bargaining Power of Suppliers: Low, with multiple material providers.
- Competitive Rivalry: High, with competition on efficacy, comfort, and smart tech.
Market Opportunities and Challenges
Opportunities:
- OSA (1 billion cases) and TMD (10%-15% prevalence) drive demand.
- Aging populations (1.5 billion over 65 by 2050) boost needs, while smart appliances enhance adoption.
- Obesity (800 million cases) increases usage.
Challenges:
- High costs of custom devices limit access in low-income regions.
- Regulatory delays for smart tech slow growth.
- Limited sleep specialists in rural areas restrict expansion.
- Market News
- In May 2024, Glidewell launched the Digital Silent Nite 3D Sleep Appliance for OSA and snoring.
- In February 2024, Sleep Doctor partnered with Airway Management to offer the myTAP Oral Appliance.
- In January 2024, ProSomnus adopted UnitedHealthcare’s policy mandating oral appliance therapy.
- In May 2023, Glidewell acquired ORB Innovations Limited for smart oral appliances.
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- ResMed
- SomnoMed
- ProSomnus
- Vivos
- Glidewell
- Airway Management (TAP)
- Mitsui Chemicals
- Signifier Medical Technologies
- Achaemenid
- Apnea Sciences